Literature DB >> 16905221

How can we define expanded criteria for liver donors?

Robert M Merion1, Nathan P Goodrich, Sandy Feng.   

Abstract

Mesh：

Year:  2006        PMID： 16905221     DOI： 10.1016/j.jhep.2006.07.016

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  12 in total

1.  Intrahepatic Delivery of Pegylated Catalase Is Protective in a Rat Ischemia/Reperfusion Injury Model.

Authors:  Clifford Akateh; Eliza W Beal; Jung-Lye Kim; Brenda F Reader; Katelyn Maynard; Jay L Zweier; Bryan A Whitson; Sylvester M Black
Journal:  J Surg Res       Date:  2019-02-13       Impact factor: 2.192

2.  Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study.

Authors:  Christine E Haugen; Alvin G Thomas; Jacqueline Garonzik-Wang; Allan B Massie; Dorry L Segev
Journal:  Transplantation       Date:  2018-09       Impact factor: 4.939

3.  The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation.

Authors:  Paolo R Salvalaggio; Nino Dzebisashvili; Kara E MacLeod; Krista L Lentine; Adrian Gheorghian; Mark A Schnitzler; Samuel Hohmann; Dorry L Segev; Sommer E Gentry; David A Axelrod
Journal:  Liver Transpl       Date:  2011-03       Impact factor: 5.799

4.  Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients.

Authors:  Christian E Oberkofler; Philipp Dutkowski; Reto Stocker; Reto A Schuepbach; John F Stover; Pierre-Alain Clavien; Markus Béchir
Journal:  Crit Care       Date:  2010-06-15       Impact factor: 9.097

5.  The combination of MELD score and ICG liver testing predicts length of stay in the ICU and hospital mortality in liver transplant recipients.

Authors:  Stephanie Klinzing; Giovanna Brandi; Paul A Stehberger; Dimitri A Raptis; Markus Béchir
Journal:  BMC Anesthesiol       Date:  2014-11-15       Impact factor: 2.217

6.  Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion.

Authors:  Michael E Sutton; Sanna op den Dries; Negin Karimian; Pepijn D Weeder; Marieke T de Boer; Janneke Wiersema-Buist; Annette S H Gouw; Henri G D Leuvenink; Ton Lisman; Robert J Porte
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

7.  Transplantation of high-risk donor livers after resuscitation and viability assessment using a combined protocol of oxygenated hypothermic, rewarming and normothermic machine perfusion: study protocol for a prospective, single-arm study (DHOPE-COR-NMP trial).

Authors:  Yvonne de Vries; Tim A Berendsen; Masato Fujiyoshi; Aad P van den Berg; Hans Blokzijl; Marieke T de Boer; Frans van der Heide; Ruben H J de Kleine; Otto B van Leeuwen; Alix P M Matton; Maureen J M Werner; Ton Lisman; Vincent E de Meijer; Robert Porte
Journal:  BMJ Open       Date:  2019-08-15       Impact factor: 2.692

8.  The relationship between preoperative creatinine clearance and outcomes for patients undergoing liver transplantation: a retrospective observational study.

Authors:  Urs Wenger; Thomas A Neff; Christian E Oberkofler; Manuel Zimmermann; Paul A Stehberger; Marcel Scherrer; Reto A Schuepbach; Silvia R Cottini; Peter Steiger; Markus Béchir
Journal:  BMC Nephrol       Date:  2013-02-14       Impact factor: 2.388

9.  A proposal to grade the severity of early allograft dysfunction after liver transplantation.

Authors:  Paolo Salvalaggio; Rogerio Carballo Afonso; Guilherme Felga; Ben-Hur Ferraz-Neto
Journal:  Einstein (Sao Paulo)       Date:  2013 Jan-Mar

Review 10.  Normothermic Ex-vivo Liver Perfusion and the Clinical Implications for Liver Transplantation.

Authors:  Clifford Akateh; Eliza W Beal; Bryan A Whitson; Sylvester M Black
Journal:  J Clin Transl Hepatol       Date:  2018-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.